Important updates for Beckman MLPA users relating to a new version of Coffalyser.Net with improved quality checks and the gradual phasing out of our Cy5-labelled primers. Read more.
A new publication by researchers at MRC Holland highlights the potential of EZtec-MS, a new variation of the digitalMLPA technology, for newborn screening purposes. Read more.
Our digitalMLPA™ portfolio is about to receive an update with the upcoming launch of NXtec D038 Carrier Plus – the expanded version of our digitalMLPA assay for carrier status analysis. Read more.
At MRC Holland, we are gradually updating probe location annotations across our product documentation to align with MANE (Matched Annotation from NCBI and EMBL-EBI). Read more.
We have reviewed our pricing structure for 2027 and effective from January 1st, 2027, our list prices will increase by an average of 2.9%, with variations depending on product category. Read more.
We are pleased to announce new distribution partners in Mexico and Egypt, further strengthening access to MRC Holland products for laboratories in these countries. Read more.
MRC Holland and Amsterdam UMC have launched a collaborative project, supported by Health~Holland, and aimed at improving the reliability of patient-derived stem cell models used in personalized medicine. Read more.
We've made it easier to explore our product portfolio. You can now view the regions targeted by all our products through custom tracks on the UCSC Genome Browser. Read more.
A new version of Coffalyser digitalMLPA – version 2.6 – was recently released. This update further improves the robustness, reliability, and usability of digitalMLPA data analysis. Read more.
June marked another outstanding edition of the European Human Genetics Conference, during which we got up to speed with the latest developments in human genetics, and introduced digitalMLPA to an even wider audience. Read more.
Join our mailing list to receive the latest information about our products, technologies and website.